n-PropyIthiouracil as a Genetic Taste Marker for Fat Intake, Obesity, and Chronic Disease Risk Current Evidence and Future Promise

Author(s):  
Megan Racey ◽  
Amanda J. MacFarlane ◽  
S Carlson ◽  
Ken D Stark ◽  
Melanie Plourde ◽  
...  

Given the focus on developing Dietary Reference Intakes (DRIs) based on chronic disease risk reduction and recent research for omega-3 long chain PUFA since the last DRI review, the Canadian Nutrition Society convened a panel of stakeholders for a one-day workshop in late 2019. Attendees discussed the new NASEM guidelines for establishing DRI values based on chronic disease risk endpoints and the strength of current evidence for EPA and DHA as it relates to the new guidelines. Novelty: Summarizes evidence and expert opinions regarding the potential for reviewing DRI values for EPA and DHA and cardiovascular disease risk and early development.


2016 ◽  
Vol 116 (9) ◽  
pp. 1553-1563 ◽  
Author(s):  
Sam R. Emerson ◽  
Mark D. Haub ◽  
Colby S. Teeman ◽  
Stephanie P. Kurti ◽  
Sara K. Rosenkranz

AbstractResearch points to postprandial glucose and TAG measures as preferable assessments of cardiovascular risk as compared with fasting values. Although elevated postprandial glycaemic and lipaemic responses are thought to substantially increase chronic disease risk, postprandial glycaemia and lipaemia have historically only been considered separately. However, carbohydrates and fats can generally ‘compete’ for clearance from the stomach, small intestine, bloodstream and within the peripheral cell. Further, there are previous data demonstrating that the addition of carbohydrate to a high-fat meal blunts the postprandial lipaemic response, and the addition of fat to a high-carbohydrate meal blunts the postprandial glycaemic response. Thus, postprandial glycaemia and lipaemia are interrelated. The purpose of this brief review is 2-fold: first, to review the current evidence implicating postprandial glycaemia and lipaemia in chronic disease risk, and, second, to examine the possible utility of a single postprandial glycaemic and lipaemic summative value, which will be referred to as the metabolic load index. The potential benefits of the metabolic load index extend to the clinician, patient and researcher.


1994 ◽  
Vol 10 (6) ◽  
pp. 367-371 ◽  
Author(s):  
Carol Friedman ◽  
Ross C. Brownson ◽  
Dan E. Peterson ◽  
Joan C. Wilkerson

Author(s):  
Mariana Zogbi Jardim ◽  
Bruna Vieira de Lima Costa ◽  
Milene Cristine Pessoa ◽  
Camila Kümmel Duarte

2012 ◽  
Vol 27 (6) ◽  
pp. 81-85 ◽  
Author(s):  
Christopher A. Harle ◽  
Daniel B. Neill ◽  
Rema Padman

Sign in / Sign up

Export Citation Format

Share Document